title: Physical Activity and the Risk of Primary Hyperparathyroidism.
abstract: Primary hyperparathyroidism (P-HPTH) is relatively common and predominantly affects women. Prior studies have shown that physical activity (PA) can lower PTH levels.
  
  
  
  Our objective was to evaluate the hypothesis that lower PA is a risk factor for developing P-HPTH.
  
  
  
  This prospective cohort study included 69 621 female participants in the Nurses' Health Study I followed for 22 years.
  
  
  
  PA and other dietary and demographic exposures were quantified via detailed, and validated, biennial questionnaires.
  
  
  
  Incident P-HPTH was confirmed by medical record review after initial assessment by questionnaire. Adjusted Cox proportional hazards models were used to evaluate whether PA was an independent risk factor for developing P-HPTH. We also evaluated the risk of developing P-HPTH when combining low PA (<16 metabolic equivalent hours/week) with a previously identified independent risk factor for developing P-HPTH: low calcium intake (<800 mg/day). The relation between PA and PTH levels was evaluated in 625 participants.
  
  
  
  We confirmed 302 incident cases of P-HPTH during 1 474 993 person-years of follow-up. Participants in the highest quintile (Q) of PA had a 50% lower risk of developing P-HPTH: age-adjusted relative risks and 95% confidence intervals for incident P-HPTH by lowest to highest of PA were Q1 = 1.0 (reference); Q2 = 0.83 (0.60–1.15); Q3 = 0.84 (0.61–1.15); Q4 = 0.50 (0.34–0.74); Q5 = 0.50 (0.35–0.73); P for trend <.001. Extensive multivariable adjustments did not materially change these findings. The adjusted relative risk for developing P-HPTH among participants with the combination lower PA and lower calcium intake was 2.37-fold (1.60–3.51) higher than in participants with higher PA and higher calcium intake. PA was inversely correlated with serum PTH (ρ = −0.09, P = .03); the mean adjusted serum PTH in Q 2–5 of PA was lower than in Q 1 (36.3 vs 39.1 pg/mL, P = .02).
  
  
  
  Low physical activity may be a modifiable risk factor for developing P-HPTH in women.
authors.affiliation: Division of Endocrinology, Diabetes, and Hypertension (A.V.), Division of Renal Medicine (G.C.C., J.M.P.), Channing Division of Network Medicine (G.C.C., J.M.P., E.N.T.), Brigham and Women's Hospital (A.V., G.C.C., J.M.P., E.N.T.), Boston, Massachusetts; Harvard Medical School (A.V., J.M.P.), Boston, Massachusetts; Department of Epidemiology (G.C.C. J.M.P., M.W.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of Nephrology and Transplantation (E.N.T.), Maine Medical Center, Portland, Maine 02115.
authors.forename: Anand
authors.initials: A
authors.lastname: Vaidya
authors.affiliation: Division of Endocrinology, Diabetes, and Hypertension (A.V.), Division of Renal Medicine (G.C.C., J.M.P.), Channing Division of Network Medicine (G.C.C., J.M.P., E.N.T.), Brigham and Women's Hospital (A.V., G.C.C., J.M.P., E.N.T.), Boston, Massachusetts; Harvard Medical School (A.V., J.M.P.), Boston, Massachusetts; Department of Epidemiology (G.C.C. J.M.P., M.W.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of Nephrology and Transplantation (E.N.T.), Maine Medical Center, Portland, Maine 02115.
authors.forename: Gary C
authors.initials: GC
authors.lastname: Curhan
authors.affiliation: Division of Endocrinology, Diabetes, and Hypertension (A.V.), Division of Renal Medicine (G.C.C., J.M.P.), Channing Division of Network Medicine (G.C.C., J.M.P., E.N.T.), Brigham and Women's Hospital (A.V., G.C.C., J.M.P., E.N.T.), Boston, Massachusetts; Harvard Medical School (A.V., J.M.P.), Boston, Massachusetts; Department of Epidemiology (G.C.C. J.M.P., M.W.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of Nephrology and Transplantation (E.N.T.), Maine Medical Center, Portland, Maine 02115.
authors.forename: Julie M
authors.initials: JM
authors.lastname: Paik
authors.affiliation: Division of Endocrinology, Diabetes, and Hypertension (A.V.), Division of Renal Medicine (G.C.C., J.M.P.), Channing Division of Network Medicine (G.C.C., J.M.P., E.N.T.), Brigham and Women's Hospital (A.V., G.C.C., J.M.P., E.N.T.), Boston, Massachusetts; Harvard Medical School (A.V., J.M.P.), Boston, Massachusetts; Department of Epidemiology (G.C.C. J.M.P., M.W.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of Nephrology and Transplantation (E.N.T.), Maine Medical Center, Portland, Maine 02115.
authors.forename: Molin
authors.initials: M
authors.lastname: Wang
authors.affiliation: Division of Endocrinology, Diabetes, and Hypertension (A.V.), Division of Renal Medicine (G.C.C., J.M.P.), Channing Division of Network Medicine (G.C.C., J.M.P., E.N.T.), Brigham and Women's Hospital (A.V., G.C.C., J.M.P., E.N.T.), Boston, Massachusetts; Harvard Medical School (A.V., J.M.P.), Boston, Massachusetts; Department of Epidemiology (G.C.C. J.M.P., M.W.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of Nephrology and Transplantation (E.N.T.), Maine Medical Center, Portland, Maine 02115.
authors.forename: Eric N
authors.initials: EN
authors.lastname: Taylor
mesh_terms: D000328:Adult; D015444:Exercise / Q000502:physiology*; D005260:Female; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control*; D015994:Incidence; D008281:Maine / Q000453:epidemiology; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors
references.citation: Am J Epidemiol. 1985 Jul;122(1):51-65
references.pmid: 4014201
references.citation: J Clin Endocrinol Metab. 2015 Jun;100(6):2396-404
references.pmid: 25885946
references.citation: Int J Epidemiol. 1989 Dec;18(4):858-67
references.pmid: 2621022
references.citation: J Clin Endocrinol Metab. 2014 May;99(5):1774-82
references.pmid: 24476072
references.citation: Am J Epidemiol. 1987 Aug;126(2):319-25
references.pmid: 3605058
references.citation: Br J Nutr. 2012 Nov 28;108(10):1889-96
references.pmid: 22264926
references.citation: BMJ. 2012 Oct 17;345:e6390
references.pmid: 23080543
references.citation: J Clin Endocrinol Metab. 2010 Aug;95(8):3918-25
references.pmid: 20519353
references.citation: J Appl Physiol (1985). 2011 Feb;110(2):423-32
references.pmid: 21127210
references.citation: Sports Med. 2005;35(9):779-830
references.pmid: 16138787
references.citation: Med Sci Sports Exerc. 1993 Jan;25(1):71-80
references.pmid: 8292105
references.citation: N Engl J Med. 2004 Apr 22;350(17):1746-51
references.pmid: 15103001
references.citation: Lancet. 2009 Jul 11;374(9684):145-58
references.pmid: 19595349
references.citation: J Clin Endocrinol Metab. 2013 Mar;98(3):1122-9
references.pmid: 23418315
references.citation: J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9
references.pmid: 25162665
references.citation: N Engl J Med. 2013 Dec 26;369(26):2563
references.pmid: 24369084
references.citation: J Bone Miner Res. 2012 Jun;27(6):1381-9
references.pmid: 22407786
references.citation: Epidemiology. 1990 Nov;1(6):466-73
references.pmid: 2090285
references.citation: Osteoporos Int. 2009 Oct;20(10 ):1725-33
references.pmid: 19262975
references.citation: J Clin Endocrinol Metab. 2015 Feb;100(2):490-9
references.pmid: 25412416
references.citation: Int J Cancer. 2007 Dec 15;121(12):2776-81
references.pmid: 17722094
references.citation: JAMA. 2002 Nov 13;288(18):2300-6
references.pmid: 12425707
references.citation: Calcif Tissue Int. 2007 Jun;80(6):359-65
references.pmid: 17549534
references.citation: Int J Epidemiol. 1994 Oct;23(5):991-9
references.pmid: 7860180
references.citation: Atherosclerosis. 2004 Dec;177(2):375-81
references.pmid: 15530913